Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,472 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical relevance of oncogenic driver mutations identified in endometrial carcinoma.
Watanabe T, Nanamiya H, Kojima M, Nomura S, Furukawa S, Soeda S, Tanaka D, Isogai T, Imai JI, Watanabe S, Fujimori K. Watanabe T, et al. Among authors: watanabe s. Transl Oncol. 2021 Mar;14(3):101010. doi: 10.1016/j.tranon.2021.101010. Epub 2021 Jan 12. Transl Oncol. 2021. PMID: 33450701 Free PMC article.
Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues.
Tamura H, Higa A, Hoshi H, Hiyama G, Takahashi N, Ryufuku M, Morisawa G, Yanagisawa Y, Ito E, Imai JI, Dobashi Y, Katahira K, Soeda S, Watanabe T, Fujimori K, Watanabe S, Takagi M. Tamura H, et al. Among authors: watanabe s, watanabe t. Oncol Rep. 2018 Aug;40(2):635-646. doi: 10.3892/or.2018.6501. Epub 2018 Jun 18. Oncol Rep. 2018. PMID: 29917168 Free PMC article.
Tumor mutation burden and immunological, genomic, and clinicopathological factors as biomarkers for checkpoint inhibitor treatment of patients with non-small-cell lung cancer.
Ozaki Y, Muto S, Takagi H, Watanabe M, Inoue T, Fukuhara M, Yamaura T, Okabe N, Matsumura Y, Hasegawa T, Ohsugi J, Hoshino M, Shio Y, Tanaka D, Nanamiya H, Imai JI, Isogai T, Watanabe S, Suzuki H. Ozaki Y, et al. Among authors: watanabe s, watanabe m. Cancer Immunol Immunother. 2020 Jan;69(1):127-134. doi: 10.1007/s00262-019-02446-1. Epub 2019 Dec 6. Cancer Immunol Immunother. 2020. PMID: 31807880 Free PMC article.
Tumor β-catenin expression is associated with immune evasion in non-small cell lung cancer with high tumor mutation burden.
Muto S, Ozaki Y, Yamaguchi H, Mine H, Takagi H, Watanabe M, Inoue T, Yamaura T, Fukuhara M, Okabe N, Matsumura Y, Hasegawa T, Osugi J, Hoshino M, Higuchi M, Shio Y, Nanamiya H, Imai JI, Isogai T, Watanabe S, Suzuki H. Muto S, et al. Among authors: watanabe s, watanabe m. Oncol Lett. 2021 Mar;21(3):203. doi: 10.3892/ol.2021.12464. Epub 2021 Jan 12. Oncol Lett. 2021. PMID: 33574942 Free PMC article.
Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non-Small Cell Lung Cancer: Brief Report.
Owada-Ozaki Y, Muto S, Takagi H, Inoue T, Watanabe Y, Fukuhara M, Yamaura T, Okabe N, Matsumura Y, Hasegawa T, Ohsugi J, Hoshino M, Shio Y, Nanamiya H, Imai JI, Isogai T, Watanabe S, Suzuki H. Owada-Ozaki Y, et al. Among authors: watanabe s, watanabe y. J Thorac Oncol. 2018 Aug;13(8):1217-1221. doi: 10.1016/j.jtho.2018.04.003. Epub 2018 Apr 12. J Thorac Oncol. 2018. PMID: 29654927 Free article.
Family with sequence similarity 83, member B is a predictor of poor prognosis and a potential therapeutic target for lung adenocarcinoma expressing wild-type epidermal growth factor receptor.
Yamaura T, Ezaki J, Okabe N, Takagi H, Ozaki Y, Inoue T, Watanabe Y, Fukuhara M, Muto S, Matsumura Y, Hasegawa T, Hoshino M, Osugi J, Shio Y, Waguri S, Tamura H, Imai JI, Ito E, Yanagisawa Y, Honma R, Watanabe S, Suzuki H. Yamaura T, et al. Among authors: watanabe s, watanabe y. Oncol Lett. 2018 Feb;15(2):1549-1558. doi: 10.3892/ol.2017.7517. Epub 2017 Dec 5. Oncol Lett. 2018. PMID: 29434849 Free PMC article.
10,472 results
You have reached the last available page of results. Please see the User Guide for more information.